Skip to main content

GLYCOPYRROLATE

NDC 51662-1431 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameGLYCOPYRROLATE
Dosage formINJECTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)GLYCOPYRROLATE
Strength1 mg/5mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
Marketing categoryANDA

Packages

51662-1431-1 — 5 mL in 1 VIAL (51662-1431-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42023-269 — neostigmine methylsulfate and glycopyrrolate, 43547-543 — glycopyrrolate, 43547-544 — glycopyrrolate, 43547-639 — glycopyrrolate, 43547-640 — glycopyrrolate, 49884-042 — Glycopyrrolate, 49884-065 — glycopyrrolate, 49884-066 — glycopyrrolate, 50268-363 — Glycopyrrolate, 51662-1425 — GLYCOPYRROLATE, 51662-1484 — GLYCOPYRROLATE, 51662-1487 — GLYCOPYRROLATE, 51662-1554 — GLYCOPYRROLATE, 51662-1601 — GLYCOPYRROLATE, 51672-5316 — Glycopyrrolate Oral Solution, 51754-6000 — glycopyrrolate, 51754-6001 — glycopyrrolate, 51754-6013 — glycopyrrolate, 51754-6015 — glycopyrrolate, 55111-648 — Glycopyrrolate, +177 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.